Schizophrenia Archives

Live Event – Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder

Article June 14, 2022 6:30 pm to 7:30 pm PDT

Speaker Leon Ravin, MD is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc.Speaker Laura Brennan, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. PSYCHU PROGRAM…

Virtual Event – Proposed Role Of Modulating Norepinephrine In Psychiatry Illnesses

Article June 7, 2022 7:00 pm to 8:00 pm PDT

Speakers Sucharita Somkuwar, PhD, BPharm and Laura Brennan, PhD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Virtual Event – Proposed Role Of Modulating Norepinephrine In Psychiatry Illnesses

Article June 28, 2022 12:00 pm to 1:00 pm PDT

Speakers Sucharita Somkuwar, PhD, BPharm and Laura Brennan, PhD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Live Event – Proposed Role Of Modulating Norepinephrine In Psychiatry Illnesses

Article June 7, 2022 12:00 pm to 1:00 pm PDT

Speaker Sucharita Somkuwar, PhD, BPharm is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc.,…

Live Event – Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder

Article June 21, 2022 6:30 pm to 8:30 pm EDT

Speaker Joseph Goldberg, MD is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc.Speakers Jehan Marino, PharmD, BCPP and Erika Modh, PharmD are employees of Otsuka Pharmaceutical Development &…

Live Event – Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder

Article May 25, 2022 6:00 pm to 7:00 pm EDT

Speaker Bennett Doughty, PharmD, BCPS, BCPP is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc.Speaker Sara A. Spencer, PharmD, MS, BCGP is an employee of Otsuka Pharmaceutical Development…

Live Event – Importance of Adherence to Outcomes in Schizophrenia & Bipolar Disorder

Article May 19, 2022 6:00 pm to 8:00 pm EDT

PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc., Otsuka America Pharmaceutical, Inc., and Lundbeck, L.L.C., committed supporters of the mental health treatment community;…

Live Event – Proposed Role Of Modulating Norepinephrine In Psychiatry Illnesses

Article July 13, 2022 6:00 pm to 8:00 pm EDT

Speakers Becky Wong, PharmD, MBA and Brijesh Patel, PharmD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by Otsuka Pharmaceutical Developmental…

Virtual Event – Importance of Adherence to Outcomes in Schizophrenia & Bipolar Disorder

Article June 16, 2022 12:00 pm to 1:00 pm EDT

Speakers Dennis Sholler, PhD and Amica Simmons-Yon, PharmD, PhD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Live Event – Proposed Role of Modulating Norepinephrine in Psychiatry Illnesses

Article May 18, 2022 6:00 pm to 8:00 pm EDT

Speaker Salvatore G. Savatta, MD is a paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.Speakers Becky Wong, PharmD, MBA and Brijesh Patel, PharmD are employees of Otsuka Pharmaceutical Development…

Virtual Event – Proposed Role Of Modulating Norepinephrine In Psychiatric Illnesses

Article May 9, 2022 2:00 pm to 3:00 pm EDT

Speakers Dennis Sholler, PhD and Simon Kim, PharmD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.

Virtual Event – Distinguishing Sedation VS Efficacy In Antipsychotic Treatment

Article June 14, 2022 12:00 pm to 1:00 pm CDT

Speaker Stephen R Saklad, PharmD, BCPP is a paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.Speaker Dennis Pabis, PharmD, BCPP is an employee of Otsuka Pharmaceutical Development & Commercialization,…

Virtual Event – Considerations & Factors For Initiating & Switching Antipsychotic Medications In Schizophrenia

Article April 26, 2022 12:00 pm to 1:00 pm EDT

Speaker Salvatore G. Savatta, MD is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc.Speakers Becky Wong, PharmD, MBA and Brijesh Patel, PharmD are employees of Otsuka Pharmaceutical Development…

Virtual Event – Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder

Article April 12, 2022 2:00 pm to 3:00 pm EDT

Speaker Martin Guerrero, MD, JD is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc.Speaker Jessie Chambers, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Live Event – Addressing The Transition Of Care For Patients With Schizophrenia: A Case Study Approach

Article March 23, 2022 6:30 pm to 7:30 pm PDT

Speakers Hiten Patadia, PharmD and Sucharita Somkuwar, PhD, BPharm are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by Otsuka Pharmaceutical Developmental…

Live Event – Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder

Article April 14, 2022 6:30 pm to 7:30 pm PDT

Speaker David Block, MD, MMM is a paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.Speaker Sucharita Somkuwar, PhD, BPharm is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.…

Live Event – Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder

Article March 15, 2022 3:00 pm to 4:00 pm EDT

Speaker Sucharita Somkuwar, PhD BPharm is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc.,…

Schizophrenia

Live Event – Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder

Virtual Event – Proposed Role Of Modulating Norepinephrine In Psychiatry Illnesses

Virtual Event – Proposed Role Of Modulating Norepinephrine In Psychiatry Illnesses

Live Event – Proposed Role Of Modulating Norepinephrine In Psychiatry Illnesses

Live Event – Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder

Live Event – Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder

Live Event – Importance of Adherence to Outcomes in Schizophrenia & Bipolar Disorder

Live Event – Proposed Role Of Modulating Norepinephrine In Psychiatry Illnesses

Virtual Event – Importance of Adherence to Outcomes in Schizophrenia & Bipolar Disorder

Live Event – Proposed Role of Modulating Norepinephrine in Psychiatry Illnesses

Virtual Event – Proposed Role Of Modulating Norepinephrine In Psychiatric Illnesses

Virtual Event – Distinguishing Sedation VS Efficacy In Antipsychotic Treatment

Virtual Event – Considerations & Factors For Initiating & Switching Antipsychotic Medications In Schizophrenia

Virtual Event – Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder

Live Event – Addressing The Transition Of Care For Patients With Schizophrenia: A Case Study Approach

Live Event – Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder

Live Event – Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder

Virtual Event – Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder

Live Event – Metabolic Wellness Consideration In Schizophrenia

Live Events – Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder

Virtual Event – Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder

Live Event – Proposed Role Of Modulating Norepinephrine In Psychiatry Illnesses

Virtual Event – Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder

Virtual Event – Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder

Virtual Event – Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder

Virtual Event – Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder

Now Leaving PsychU

This link will take you outside of the PsychU community website

Stay Connected: